Memory Disorders
84
15
20
44
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
13 trials with published results (15%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.6%
3 terminated out of 84 trials
93.6%
+7.1% vs benchmark
6%
5 trials in Phase 3/4
30%
13 of 44 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 44 completed trials
Clinical Trials (84)
Neural Basis of Human Working Memory
Human Cognition During Surgery: Stimulation-based and Cholinergic Modulation
Pilot Study on the Feasibility of Using Smartphone Data as a Diagnostic Marker for Alzheimer's Disease
Brain Health Virtual Reality Study
Investigation of AlzHeimer's Predictors in Subjective Memory Complainers - Extension Study
Neural Correlates of Psychiatric Disorders
Virtual Reality Cognitive Stimulation for Alzheimer's
Spatial Scene Recognition Memory in Epilepsy Surgery
Creation of an Ecological Tool Assessing Episodic Memory in Geriatrics
Development, Standardisation and Standardisation Project for a New Memory Assessment
A Study of HD-tDCS and Cognitive Training to Improve Cognitive Function in MCI
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
Treatment of Memory Disorders in Gulf War Illness With High Definition Transcranial Direct Cortical Stimulation
HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH)-Parkinson's Disease (HOBSCOTCH-Parkinson's)
Nutrition-based Interventions to Prevent Cognitive Decline
A Study of Retinal Imaging to Detect Abnormal Protein Deposits Associated With Alzheimer's Disease
HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH) - Multiple Sclerosis (MS)
HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
HOBSCOTCH-MS-Efficacy Trial
Brain Boosters 2 in Persons at Risk for Alzheimer's Disease: a Digital Application Supported Intervention